Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid
Abstract Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed. A 77‐year‐old woman with metastatic maligna...
Na minha lista:
Principais autores: | , , |
---|---|
Formato: | Livro |
Publicado em: |
Wiley,
2023-03-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Número de Chamada: |
A1234.567 |
---|---|
Cópia 1 | Disponível |